Medical Technology

@xconomy.com 3 years ago

HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic

@xconomy.com 4 years ago

Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers

@xconomy.com 4 years ago

Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug

@xconomy.com 4 years ago

Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More

@xconomy.com 5 years ago

FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea

@xconomy.com 5 years ago

Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More

@xconomy.com 5 years ago

With New Data, Intercept On Track for First-Ever Approved NASH Drug

@xconomy.com 5 years ago

Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms

@xconomy.com 5 years ago

ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On